Advances in Hematological Malignancies
Recent years have witnessed remarkable strides in the area of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and therapy are transforming the survival rates for patients with blood cancers. Research studies continue to explore these innovative strategies, offering hope for more successful treatment options.